TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy

Johanna Ábrigo, Fabian Campos, Felipe Simon, Claudia Riedel, Daniel Cabrera, Cristian Vilos, Claudio Cabello-Verrugio

Resultado de la investigación: Contribución a la publicaciónArticle

Resumen

The transforming growth factor type-beta (TGF-β) induces skeletal muscle atrophy characterised by a decrease in the fibre's diameter and levels of myosin heavy chain (MHC), also as an increase of MuRF-1 expression. In addition, TGF-β induces muscle atrophy by a mechanism dependent on reactive oxygen species (ROS). TGF-β signals by activating both canonical Smad-dependent, and non-canonical signalling pathways such as ERK1/2, JNK1/2, and p38 MAPKs. However, the participation of canonical and non-canonical signalling pathways in the TGF-β atrophic effect on skeletal muscle is unknown. We evaluate the impact of Smad and MAPK signalling pathways on the TGF-β-induced atrophic effect in C2C12 myotubes. The results indicate that TGF-β activates Smad2/3, ERK1/2 and JNK1/2, but not p38 in myotubes. The pharmacological inhibition of Smad3, ERK1/2 and JNK1/2 activation completely abolished the atrophic effect of TGF-β. Finally, the inhibition of these canonical and non-canonical pathways did not decrease the ROS increment, while the inhibition of ROS production entirely abolished the phosphorylation of Smad3, ERK1/2 and JNK1/2. These results suggest that TGF-β requires Smad3, ERK1/2 and JNK1/2 activation to produce skeletal muscle atrophy. Moreover, the induction of ROS by TGF-β is an upstream event to canonical and non-canonical pathways.

IdiomaEnglish
Páginas253-264
Número de páginas12
PublicaciónBiological Chemistry
Volumen399
Número de edición3
DOI
EstadoPublished - 23 feb 2018

Huella dactilar

Muscular Atrophy
Transforming Growth Factor beta
Muscle
Skeletal Muscle
Chemical activation
Reactive Oxygen Species
Skeletal Muscle Fibers
Phosphorylation
Myosin Heavy Chains
p38 Mitogen-Activated Protein Kinases
Pharmacology

Keywords

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Biology
    • Clinical Biochemistry

    Citar esto

    @article{98acde4819ce4145bdf8ca495a7218fc,
    title = "TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy",
    abstract = "The transforming growth factor type-beta (TGF-β) induces skeletal muscle atrophy characterised by a decrease in the fibre's diameter and levels of myosin heavy chain (MHC), also as an increase of MuRF-1 expression. In addition, TGF-β induces muscle atrophy by a mechanism dependent on reactive oxygen species (ROS). TGF-β signals by activating both canonical Smad-dependent, and non-canonical signalling pathways such as ERK1/2, JNK1/2, and p38 MAPKs. However, the participation of canonical and non-canonical signalling pathways in the TGF-β atrophic effect on skeletal muscle is unknown. We evaluate the impact of Smad and MAPK signalling pathways on the TGF-β-induced atrophic effect in C2C12 myotubes. The results indicate that TGF-β activates Smad2/3, ERK1/2 and JNK1/2, but not p38 in myotubes. The pharmacological inhibition of Smad3, ERK1/2 and JNK1/2 activation completely abolished the atrophic effect of TGF-β. Finally, the inhibition of these canonical and non-canonical pathways did not decrease the ROS increment, while the inhibition of ROS production entirely abolished the phosphorylation of Smad3, ERK1/2 and JNK1/2. These results suggest that TGF-β requires Smad3, ERK1/2 and JNK1/2 activation to produce skeletal muscle atrophy. Moreover, the induction of ROS by TGF-β is an upstream event to canonical and non-canonical pathways.",
    keywords = "MAPK, MuRF-1, muscle atrophy, reactive oxygen species, Smad",
    author = "Johanna {\'A}brigo and Fabian Campos and Felipe Simon and Claudia Riedel and Daniel Cabrera and Cristian Vilos and Claudio Cabello-Verrugio",
    year = "2018",
    month = "2",
    day = "23",
    doi = "10.1515/hsz-2017-0217",
    language = "English",
    volume = "399",
    pages = "253--264",
    journal = "Biological Chemistry",
    issn = "1431-6730",
    publisher = "Walter de Gruyter GmbH",
    number = "3",

    }

    TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy. / Ábrigo, Johanna; Campos, Fabian; Simon, Felipe; Riedel, Claudia; Cabrera, Daniel; Vilos, Cristian; Cabello-Verrugio, Claudio.

    En: Biological Chemistry, Vol. 399, N.º 3, 23.02.2018, p. 253-264.

    Resultado de la investigación: Contribución a la publicaciónArticle

    TY - JOUR

    T1 - TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy

    AU - Ábrigo,Johanna

    AU - Campos,Fabian

    AU - Simon,Felipe

    AU - Riedel,Claudia

    AU - Cabrera,Daniel

    AU - Vilos,Cristian

    AU - Cabello-Verrugio,Claudio

    PY - 2018/2/23

    Y1 - 2018/2/23

    N2 - The transforming growth factor type-beta (TGF-β) induces skeletal muscle atrophy characterised by a decrease in the fibre's diameter and levels of myosin heavy chain (MHC), also as an increase of MuRF-1 expression. In addition, TGF-β induces muscle atrophy by a mechanism dependent on reactive oxygen species (ROS). TGF-β signals by activating both canonical Smad-dependent, and non-canonical signalling pathways such as ERK1/2, JNK1/2, and p38 MAPKs. However, the participation of canonical and non-canonical signalling pathways in the TGF-β atrophic effect on skeletal muscle is unknown. We evaluate the impact of Smad and MAPK signalling pathways on the TGF-β-induced atrophic effect in C2C12 myotubes. The results indicate that TGF-β activates Smad2/3, ERK1/2 and JNK1/2, but not p38 in myotubes. The pharmacological inhibition of Smad3, ERK1/2 and JNK1/2 activation completely abolished the atrophic effect of TGF-β. Finally, the inhibition of these canonical and non-canonical pathways did not decrease the ROS increment, while the inhibition of ROS production entirely abolished the phosphorylation of Smad3, ERK1/2 and JNK1/2. These results suggest that TGF-β requires Smad3, ERK1/2 and JNK1/2 activation to produce skeletal muscle atrophy. Moreover, the induction of ROS by TGF-β is an upstream event to canonical and non-canonical pathways.

    AB - The transforming growth factor type-beta (TGF-β) induces skeletal muscle atrophy characterised by a decrease in the fibre's diameter and levels of myosin heavy chain (MHC), also as an increase of MuRF-1 expression. In addition, TGF-β induces muscle atrophy by a mechanism dependent on reactive oxygen species (ROS). TGF-β signals by activating both canonical Smad-dependent, and non-canonical signalling pathways such as ERK1/2, JNK1/2, and p38 MAPKs. However, the participation of canonical and non-canonical signalling pathways in the TGF-β atrophic effect on skeletal muscle is unknown. We evaluate the impact of Smad and MAPK signalling pathways on the TGF-β-induced atrophic effect in C2C12 myotubes. The results indicate that TGF-β activates Smad2/3, ERK1/2 and JNK1/2, but not p38 in myotubes. The pharmacological inhibition of Smad3, ERK1/2 and JNK1/2 activation completely abolished the atrophic effect of TGF-β. Finally, the inhibition of these canonical and non-canonical pathways did not decrease the ROS increment, while the inhibition of ROS production entirely abolished the phosphorylation of Smad3, ERK1/2 and JNK1/2. These results suggest that TGF-β requires Smad3, ERK1/2 and JNK1/2 activation to produce skeletal muscle atrophy. Moreover, the induction of ROS by TGF-β is an upstream event to canonical and non-canonical pathways.

    KW - MAPK

    KW - MuRF-1

    KW - muscle atrophy

    KW - reactive oxygen species

    KW - Smad

    UR - http://www.scopus.com/inward/record.url?scp=85037695444&partnerID=8YFLogxK

    U2 - 10.1515/hsz-2017-0217

    DO - 10.1515/hsz-2017-0217

    M3 - Article

    VL - 399

    SP - 253

    EP - 264

    JO - Biological Chemistry

    T2 - Biological Chemistry

    JF - Biological Chemistry

    SN - 1431-6730

    IS - 3

    ER -